Efficacy and Safety of Amrubicin Monotherapy After Chemoradiotherapy in Patients With Relapsed Limited Disease Small-cell Lung Cancer

AKIRA MATSUKIDA; HISAO IMAI; AYAKO SHIONO; YASUHIRO RYUNO; KOSUKE HASHIMOTO; YU MIURA; SATOSHI ENDO; SHOHEI OKAZAKI; OU YAMAGUCHI; ATSUTO MOURI; TAKANORI ABE; KYOICHI KAIRA; KUNIHIKO KOBAYASHI; SHINGO KATO; HIROSHI KAGAMU

doi:10.21873/anticanres.17461

Research ArticleClinical Studies

Efficacy and Safety of Amrubicin Monotherapy After Chemoradiotherapy in Patients With Relapsed Limited Disease Small-cell Lung Cancer

AKIRA MATSUKIDA, HISAO IMAI, AYAKO SHIONO, YASUHIRO RYUNO, KOSUKE HASHIMOTO, YU MIURA, SATOSHI ENDO, SHOHEI OKAZAKI, OU YAMAGUCHI, ATSUTO MOURI, TAKANORI ABE, KYOICHI KAIRA, KUNIHIKO KOBAYASHI, SHINGO KATO and HIROSHI KAGAMU

Anticancer Research February 2025, 45 (2) 733-741; DOI: https://doi.org/10.21873/anticanres.17461

AKIRA MATSUKIDA

1Department of Respiratory Medicine, International Medical Center, Saitama Medical University, Saitama, Japan

2Division of Infectious Diseases and Respiratory Medicine, Department of Internal Medicine, National Defense Medical College, Saitama, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

HISAO IMAI

1Department of Respiratory Medicine, International Medical Center, Saitama Medical University, Saitama, Japan

3Division of Respiratory Medicine, Gunma Prefectural Cancer Center, Gunma, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: m06701014@gunma-u.ac.jp

AYAKO SHIONO

1Department of Respiratory Medicine, International Medical Center, Saitama Medical University, Saitama, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

YASUHIRO RYUNO

4Department of Radiation Oncology, International Medical Center, Saitama Medical University, Saitama, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

KOSUKE HASHIMOTO

1Department of Respiratory Medicine, International Medical Center, Saitama Medical University, Saitama, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

YU MIURA

1Department of Respiratory Medicine, International Medical Center, Saitama Medical University, Saitama, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

SATOSHI ENDO

3Division of Respiratory Medicine, Gunma Prefectural Cancer Center, Gunma, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

SHOHEI OKAZAKI

5Division of Radiation Oncology, Gunma Prefectural Cancer Center, Gunma, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

OU YAMAGUCHI

1Department of Respiratory Medicine, International Medical Center, Saitama Medical University, Saitama, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

ATSUTO MOURI

1Department of Respiratory Medicine, International Medical Center, Saitama Medical University, Saitama, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

TAKANORI ABE

4Department of Radiation Oncology, International Medical Center, Saitama Medical University, Saitama, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

KYOICHI KAIRA

1Department of Respiratory Medicine, International Medical Center, Saitama Medical University, Saitama, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

KUNIHIKO KOBAYASHI

1Department of Respiratory Medicine, International Medical Center, Saitama Medical University, Saitama, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

SHINGO KATO

4Department of Radiation Oncology, International Medical Center, Saitama Medical University, Saitama, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

HIROSHI KAGAMU

1Department of Respiratory Medicine, International Medical Center, Saitama Medical University, Saitama, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
PDF

Log in using your username and password

Username *

Password *

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles

PreviousNext

In this issue

Anticancer Research

Vol. 45, Issue 2

February 2025

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Back Matter (PDF)
Ed Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Efficacy and Safety of Amrubicin Monotherapy After Chemoradiotherapy in Patients With Relapsed Limited Disease Small-cell Lung Cancer

Message Subject (Your Name) has sent you a message from Anticancer Research

Message Body (Your Name) thought you would like to see the Anticancer Research web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 6 + 4 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

Efficacy and Safety of Amrubicin Monotherapy After Chemoradiotherapy in Patients With Relapsed Limited Disease Small-cell Lung Cancer

Anticancer Research Feb 2025, 45 (2) 733-741; DOI: 10.21873/anticanres.17461

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Reprints and Permissions

Efficacy and Safety of Amrubicin Monotherapy After Chemoradiotherapy in Patients With Relapsed Limited Disease Small-cell Lung Cancer

Anticancer Research Feb 2025, 45 (2) 733-741; DOI: 10.21873/anticanres.17461

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Keywords

Amrubicin
chemoradiotherapy
limited disease
relapsed small-cell lung cancer

Main menu

User menu

Search

Efficacy and Safety of Amrubicin Monotherapy After Chemoradiotherapy in Patients With Relapsed Limited Disease Small-cell Lung Cancer

Purchase access

patientACCESS

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords